Letter to the Editor
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jan 27, 2022; 14(1): 300-303
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.300
Current highlights on solid pseudopapillary neoplasm of the pancreas
Simone Sibio, Sara Di Carlo
Simone Sibio, Department of Surgery Pietro Valdoni, Sapienza University of Rome, Umberto I Hospital, Rome 00161, Italy
Sara Di Carlo, Minimally Invasive Surgery Unit, Tor Vergata Hospital, Tor Vergata University of Rome, Rome 00133, Italy
Author contributions: Both Sibio S and Di Carlo S contributed equally in revising current literature, writing the manuscript, and reviewing the drafts.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Simone Sibio, MD, PhD, Associate Professor, Surgical Oncologist, Department of Surgery Pietro Valdoni, Sapienza University of Rome, Umberto I Hospital, Viale del Policlinico 155, Rome 00161, Italy. simone.sibio@uniroma1.it
Received: September 4, 2021
Peer-review started: September 4, 2021
First decision: October 18, 2021
Revised: October 25, 2021
Accepted: January 5, 2022
Article in press: January 5, 2022
Published online: January 27, 2022
Processing time: 138 Days and 15.5 Hours
Core Tip

Core Tip: This letter aims to underline the utmost importance of early diagnosis and standardization of treatment for a subset of rare pancreatic malignant tumors that affect young women and have good prognosis when curative surgery is performed. However, little is known about clinical behavior and hormonal responsiveness of such diseases and treatment option availability is still scarce for advanced, recurrent and metastatic disease so further investigation is claimed.